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Abstract 
Rett Syndrome (RTT) is an autism-spectrum disorder caused by a mutation in the gene coding for 
methyl-CpG-binding protein 2 (MeCP2). In accordance with the theory that RTT arises from a 
excitatory/inhibitory imbalance caused by dendritic alterations, we hoped to observe reduced 
arborization in the MeCP2 mutant neurons. The dendritic morphology of pyramidal cells and 
interneurons proceeding from MeCP2 mutant and non-mutant mice were reconstructed and analyzed. 
We observed a possible difference in the area covered by the basal dendritic arborization and decreased 
dendritic complexity reflected in diminished process lengths and number of terminal segments. This 
could translate to a diminished integrative capacity in MeCP2 KO cells.  
.  
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Chapter 1: Introduction 
 Rett Syndrome (RTT, No.MIM:312750) is a neurological disorder part of the Autism Spectrum 
and one of the most common forms of cognitive impairment in females. It is characterized a period of 
normal development for the first 6-18 months, after which there is a period of stagnation and 
regression. The most common symptoms include decrease in head growth, loss of motor control, 
irregular breathing, loss of speech, social withdrawal and mental retardation [1, 2]. Patients can to 
survive into adulthood, but even under extensive treatment, they are unable to recover normal 
functions. It is known that about 80% of RTT cases are caused by mutations in the X-linked MeCP2 gene 
(methyl-CpG-binding protein 2) [3-5]   
 The mechanism of action by which MeCP2 brings about RTT symptoms is still uncertain. It has 
been proposed that RTT pathology, like other forms of cognitive deficits arises from a prolonged 
immature state of the nervous system.  Anomalies like spine dysgenesis and reduced dendritic 
arborization are consistent anatomical correlates of neuropsychiatric diseases characterized by cognitive 
impairment, like Down Syndrome and Fragile X [6, 7]. These changes in dendritic morphology can 
translate into altered synaptic function, which could account for the distorted cortical circuitry in RTT.  
 These theories have lead to studies on the morphology of MeCP2 deficient cells. In past studies, 
it has been proven that MeCP2 mutant pyramidal cells exhibit decreased spine motility, disrupting the 
normal maturation process [8]. It has also been shown that these MeCP2 mutant cells exhibit decreased 
spine density and decreased dendritic arborization [9, 10].  
 Such a detailed analysis has not been conducted in interneurons. The interest in interneurons 
comes from studies that show how alterations in neuronal GABA signaling causes Rett-like symptoms in 
mice and that MeCP2 might have a role in controlling GABA synthesis [11]. This and other work suggest 
that MeCP2 is necessary for proper excitatory/inhibitory balance [12]. Another interesting study 
indicates that adult GABAergic interneurons exhibit not only functional but also structural plasticity 
without any gross sensory input alterations [13]. In order to properly centralize and focus our project 
and also because of the wide variety of interneurons, we will be focusing our project on Fast-Spiking 
Parvalbumin expressing interneurons. Further clarification regarding the classification of interneurons 
will be dicussed in Chapter 2. 
 The disturbance in the excitatory/inhibitory balance could lead to a prolonged immature state of 
the nervous system, giving rise to the symptoms observed in RTT patients. This imbalance could be 
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brought about by dendritic alterations in the cortical neurons. Therefore, we hope to observe reduced 
arborization and decreased process length in the MeCP2 Knock-Out (KO) cortical neurons.   
 Some of the most important techniques in this study and neuroscience in general is the family of 
techniques called electrophysiology. Electrophysiology is the study of the electrical properties that exist 
within biological cells and tissues [14]. By the accurate placement of electrodes along the tissue, one can 
measure the basal electrical activity of an acute or cultured cell or tissue or their response to an induced 
electrical current passed through an electrode. It is a technique primarily used in researching the heart, 
muscles and nervous system.  
 In neuroscience there are a variety of electrophyisiology techniques that can be used to 
measure the electrical activity of neurons. For this project, we will be concerned with a technique 
whole-cell patch-clamping. Whole-cell patch-clamping is the gold-standard technique for studying single 
neuron morphology and firing properties. Whole-cell patch-clamping recording of the electrical activity 
of neurons in vivo and in vitro utilizes glass micropipettes to establish an electrical and molecular access 
to the inside of neurons. The electrical access is substantial enough to record synaptic and ion channel–
mediated changes to action potentials and firing properties that enable neurons to compute 
information and that are affected in brain disorders or by drug treatment. In addition, molecular access 
to the cell allows the infusion of dyes for morphological visualization and computational reconstruction 
[15].  
 For this project we will be conducting whole-cell patch clamp recordings and dye infusions in 
acute brain slices. The tissue is extracted from mice, sectioned and the slices are incubated in a slice 
incubation chamber before they are used. A more detailed description of the materials and methods can 
be seen in Chapter 4.  The success of the electrophysiology experiments are dependent on the viability 
of the brain slices after being incubated [16]. It is therefore extremely important that slices are 
appropriately preserved in the chamber.    
 For the design aspect of this major qualifying project, we will be concerned with designing a 
bioreactor that preserves the slices, allowing for optimal whole-cell patch clamping recording and dye 
filling. A five-stage prescriptive approach, as described in Engineering Design: A Project Based 
Introduction by Clive I. Dym and Patrick Little was followed. The following is a summary of said project 
approach and how it pertains to the design of the slice incubation chamber. 
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 The first stage, the problem definition, took the client statement to first clarify the design 
objectives and identify the constraints. It was also considered pertinent to examine the design 
stakeholders at this point. The revised client statement, objectives, constraints and stakeholder analysis 
are described throughout Chapter 5. The design specifications, functions and design alternatives were 
used to generate four alternative conceptual designs. The means and designs were based on methods 
and products available on the market. Product and patent searches were also conducted to establish 
current standards to which compare the final design. The alternative designs were based on functions-
means analysis of the desired final product. These four alternative designs were evaluated against the 
established objectives, constraints and functions to determine a final conceptual design. During the 
fourth stage, the detailed design, the final design was refined and altered based on testing and the 
fabrication specifications were determined. The fifth and final stage was the design communication 
stage in which the design was documented and submitted to the client. 
 Sections of this study also establish the significance of this work and the impact it may have on 
aspects such as the environment, economy and current research practices. Finally, conclusions from 
both the research and design portions of the project were determined in order to establish future 
recommendations if any of this work were to be carried on in the future.  
  
12 
 
1.1 Key Terms and Abbreviations:  
 
MeCP2 Methyl-CpG-Binding Protein 2 
RTT  Rett Syndrome 
BDNF Brain Derived Neurotrophic Factor 
CDKL5 Cyclin-dependent kinase-like 5 
PV Parvalbumin  
V1 Primary Visual Cortex  
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Chapter 2: Literature Review  
 
2.1 Rett Syndrome 
2.1.1 General Description 
 Rett Syndrome (RTT, No.MIM:312750) is a disorder part of the Autism Spectrum and one of the 
most common forms of mental retardation in females. It is characterized a period of normal 
development for the first 6-18 months, after which patients start missing important developmental 
milestones. This period of developmental stagnation is followed by regression, in which patients lose 
cognitive and motor abilities. The most common symptoms include decrease in head growth, loss of 
motor control, irregular breathing, seizures, social withdrawal and cognitive impairment [1, 2]. Patients 
usually survive until their mid-twenties but can to survive well into their forties. Even under extensive 
treatment, they are unable to recover normal cognitive and motor functions. There is no specific 
treatment for RTT and management is mainly symptomatic and individualized. There therapeutics that 
have been shown to improve multiple symptoms of RTT in animal models [10] currently undergoing 
clinical trials [17]. 
 It is known that about 90% of RTT cases are caused by loss-of-function mutations in the X-linked 
MECP2 gene (methyl-CpG-binding protein 2) [3-5]. This gene codes for MeCP2, a nuclear protein that 
functions as a transcriptional regulator and epigenetic and is implicated in gene silencing and chromatin 
remodeling [18]. The MECP2 gene is 112756 bp long and is composed of four exons. The most important 
functional domains are the methyl-Cp-G-binding domain (MBD), split between exons 3 and 4, and the 
transcriptional repressor domain (TRD) located in exon 4. The MBD region of the protein  binds to 
methylated CpG sites in DNA while the RD recruits co-repressors like histone deacetylases (HDACs).[19] 
The MeCP2 protein also contains two nuclear localization signals (NSL) [20].  While MeCp2 expression is 
ubiquitous throughout the body including lung, liver and spleen, it is abundant in mature neurons in the 
adult brain [19]. While it is known to be important in the development and maintenance of adult 
neurons, its particular role or mechanism of action are poorly understood.  
 To further understand how MECP2 mutations can lead further the understanding of the 
mechanism of action of MeCP2 several RTT animal models have been generated. Most of these models 
have been generated by altering the endogenous gene in mice. In some of these models, the MeCP2 
protein is undetectable in the brain [21] while in other a truncated non-functional form of the protein is 
expressed [22] or it is only absent in a specific subset of neurons [11]. For this study, we will be using the 
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mouse model described by Chen et al. 2001 [22] in which exon 3 of MECP2 is deleted from the neurons 
of pups using a neuron specific promoter-driven Cre-loxP recombination system.  
2.1.2 Molecular Characterization of RTT 
MeCP2 is a protein that binds to methylated CpGs in DNA regulates transcription by either 
activating & silencing through histone modification and is mostly found in differentiated mature neurons 
[4]. MeCP2 controls a variety of genes in the Central Nervous System (CNS), but one of its well known 
targets is Brain Derived Neurotrphic Factor (BDNF). Membrane depolarization causes the 
phosphorylation and consequent release of MeCP2 from BDNF promoter III, enabling its 
transcription[23]. Different studies have shown reduced and aberrant levels of BDNF secretion and 
expression in MeCP2 mutant brains [24, 25] 
 BDNF is involved in neuronal survival, axon branching and dendritic arborization and synaptic 
formation[26, 27]. The way BDNF carries out these diverse functions is through the activation of 
different signaling pathways through its receptor, TrkB [27]. It is known that BDNF can activate the 
AKT/mTOR and the MAPK/ERK pathways, both involved in the regulation of protein synthesis and 
synaptic plasticity and strengthening. The BDNF induced activation of the AKT/mTOR pathway results in 
the synthesis of proteins that are essential for synaptic organization and plasticity, like PSD-95 [26].  
 Recently, mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) have been identified 
in some RTT patients as well as other forms of mental retardation [28, 29].  CDKL5 mutations in the 
context of cognitive deficits are characterized by early-onset seizures experienced by these patients. The 
CDKL5 mutations identified include chromosome translocations, deletions, insertions, nonsense and 
misense mutations or mutations in the catalytic domain. While CDKL5 is known to be expressed in 
mature cortical neurons, its kinase activity is somewhat uncharacterized [30]. It has been shown that 
CDKL5 regulates neuronal morphogenesis in vivo [31]. Chen et al. (2010) selectively knocked-down 
endogenous CDKL5 in vivo using shRNA in mice (seen as shRNA#1 in Figure 1). The mice lacking CDKL5 
had smaller and less complex neurons throughout the different cortical layers. This morphological deficit 
was able to be recovered through re-expression of CDKL5. Chen et al.’s work also shows that CDKL5 
binds to Rac1, providing evidence that CDKL5 is involved in the BDNF-Rac1 actin-modification pathway.  
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Figure 1: CDKL5 is required for dendritic arborization in vivo. Taken from Chen et al. (2010)[31] 
 
2.2 Neuron Classification and Morphology  
 There are a variety of neurons that make up the excitatory and inhibitory units of the cortical 
circuit. The pyramidal cells are the excitatory unit of the cortex while internuerons are the main 
inhibitory unit. Both of these types of neurons have distinct morphological, molecular and 
electrophysiological properties. The appropriate contributions of excitatory and inhibitory synaptic 
inputs are necessary for proper neuronal functioning. A schematic of how these neurons connect can be 
seen in   Figure 2.  
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Figure 2: Oversimplified scheme of the inhibitory control of cortical pyramidal neurons by several general classes of 
GABAergic interneurons taken from Mendez & Bacci (2011)[32] 
 
A proper balance between excitation and inhibition is essential for proper neuronal 
development and functioning. The disturbance in the excitatory/inhibitory balance are thought to lead 
to a prolonged immature state of the central nervous system, giving rise to the symptoms observed in 
RTT patients. Therefore it is essential that we appropriately classify and study both populations. In this 
study, we will be analyzing both types of neuronal populations therefore it is essential that we outline 
their characteristics features. The following subchapter outlines the characteristics of pyramidal cells 
and interneurons.  
2.2.1 Pyramidal Cells 
 Pyramidal cells are the excitatory unit of the cortex. Pyramidal cells are amongst the largest 
neurons in the brain and are found in a variety of structures within the cortex. They have a very 
characteristic dendritic morphology regardless of their location. A simple schematic of pyramidal cell 
morphology can be seen in Figure 3. 
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 Pyramidal cells are characterized by the presence of a single apical dendrite and multiple basal 
dendrites. The apical dendrite emerges from the apex of the cell. In most cases the primary apical 
dendrite extends for several hundred microns before branching to form an apical tuft, consisting of 
dendrites that branch a few times before terminating. Emanating from the primary apical dendrites are 
several oblique branches, which typically branch once or twice before terminating. Several basal 
dendrites emerge from the base of the pyramidal soma. Each basal dendrite branches up to several 
times before terminating. The dendritic arbors are the means by which synaptic inputs are integrated by 
the cell.  
 Both the basal and apical dendrites of pyramidal neurons are studded with dendritic spines. 
These structures serve as the postsynaptic structure at most excitatory synaptic inputs received by the 
dendritic tree. 
2.2.2 Interneurons 
 Interneurons are neuronal cells that target pyramidal cells and modulate their activity. In most 
cases, interneurons use gamma-aminobutyric acid (GABA) to inhibit the activation of their target cells. A 
classification of interneurons can be seen in Figure 4.  
 
Apical Dendrite 
Basal Dendrite 
Cell Soma 
Figure 3: Schematic of morphology of cortical pyramidal cells 
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Figure 4: Classification of Interneurons based on target location. Taken from Markram et al. (2004)[33] 
 Interneurons variety comes not only from can target either the soma, the dendrites or the axon 
but also based on their molecular expression, location in the brain and cell morphology. For the purpose 
of our interneuron studies we will only be concerned with cortical interneurons that express 
parvalbumin.  
 Parvalbumin is a calcium binding protein that is selectively expressed in a specific and non-
overlapping gropup of interneurons in the cortex [34]. Parvalbumin expressing interneurons account for 
about 40% of the inhibitory neuron population in the cortex and are mostly found in layers II/III. Basket 
cells that target both the soma and proximal dendrites are the main types of interneurons that express 
parvalbumin. These cells have also been found to have conserved electrophysiological behavior as they 
are all classified as Fast-Spiking cells. Fast-spiking cells show increased frequency in firing rate compared 
to other cells types. A typical firing profile of a Fast-Spiking cell can be seen in Figure 5. 
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Figure 5: Reconstruction and firing profile of a Parvalbumin expressing cortical interneuron. Taken from Kawaguchie & 
Kubota (1998).[35] 
The interest in interneurons comes from studies that show how alterations in neuronal GABA 
signaling causes Rett-like symptoms in mice and that MeCP2 might have a role in controlling GABA 
synthesis [11]. This and other work suggest that MeCP2 is necessary for proper excitatory/inhibitory 
balance [12]. Another interesting study indicates that adult GABAergic interneurons exhibit not only 
functional but also structural plasticity without any gross sensory input alterations [13]. Because of the 
wide variety of interneuron morphology, we will be focusing our project on the previously described 
Fast-Spiking Parvalbumin expressing interneurons. We will not study the alterations in the electrical  
inhibition within the cortex.  
2.3 Neuron Morphology in Cognitive Disorders  
The mechanism of action by which MeCP2 brings about RTT symptoms is still uncertain. It has 
been proposed that RTT pathology, like other forms of cognitive deficits arises from a prolonged 
immature state of the nervous system.  Anomalies like spine dysgenesis and reduced dendritic 
arborization are consistent anatomical correlates of neuropsychiatric diseases characterized by cognitive 
impairment, like Down Syndrome and Fragile X [6, 7]. These changes in dendritic morphology can 
translate into altered synaptic function, which could account for the distorted cortical circuitry in RTT.  
2.3.1 Neuron Morphology in Rett Syndrome  
 The theory that altered morphology could lead to diminished cognitive functions has lead to the 
studies of neuronal structure in MeCP2 deficient cells. Past studies have shown that MeCP2 mutant 
pyramidal cells exhibit decreased dendritic spine motility in early development, disrupting the 
maturation process of synapses[8, 36]. Insulin-like Growth Factor 1 (IGF-1), a proposed therapeutic for 
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RTT has been shown to restore spine motility back to WT levels, which correlate to behavioral and 
physiological improvements in the treated mice [10]. 
  It has also been shown that these MeCP2 mutant cells exhibit decreased spine density and 
decreased dendritic arborization in their pyramidal cells as can be seen in [9, 10]  These structural 
studies have been correlated to functional studies that show reduction in excitatory synaptic 
transmission and overall network excitability [36-38].  
 
Figure 6: Pyramidal neurons in MECP2 −/y mice are smaller and less complex than those in wild-type mice. (A and B) 
Examples of Golgi staining of pyramidal neurons in layer II/III in wild-type (A) and MECP2 −/y mice (B) at 8 weeks of age (C 
and D). Taken from Kishi & Macklis. [9] 
 
  The precise mechanisms underlying the involvement of MeCP2 in regulating 
morphological and functional aspects of synaptic signaling remain to be identified. Such a detailed 
structural and functional analysis has not been conducted in cortical interneurons of MeCP2 mutant 
mice. The objective of this study will be to characterize the morphology of pyramidal and inhibitory 
neurons in the cortex of a mouse model for Rett Syndrome.  
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Chapter 3: Hypothesis and Project Purpose  
 
The disturbance in the excitatory/inhibitory balance could lead to a prolonged immature state of 
the nervous system, giving rise to the symptoms observed in RTT patients. This imbalance could be 
brought about by dendritic alterations on both the excitatory and inhibitory cortical neurons. Therefore, 
we hope to observe reduced arborization and decreased process length in the MeCP2 Knock-Out (KO) 
cortical neurons.  Our studies will focus both on pyramidal cells and interneurons.  
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Chapter 4: Materials and Methods  
 
 The methodology used to test the hypothesis included the creation of a transgenic mouse that 
expressed fluorescent markers in cells of interest, slice physiology experiments and reconstruction 
analysis using specialized software. A visual schematic of the experimental procedures can be seen in 
Figure 7. The following chapter explains each step of the procedure, as well as the materials used, in 
more detail. 
 
Figure 7: Illustration of Experimental Procedure 
Mice: P28-30 Pv.Td Tomato-MeCP2 hemizygous KO and WT littermates were obtained from breeding 
heterozygous females [22] with male mice, both on a C57BL/6 background. The breeding scheme to 
obtain the desired mice is shown below. Mice that are were PV-Cre were crossed with mice which had a 
floxed Td.Tomato gene to create a PV-Td.Tomato reporter line. These mice express Td.Tomato, a form 
of Red Flourescent Protein, in their Parvalbumin expressing cells. Male Pv-TdTomato mice were crossed 
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with heterozygous MeCP2 KO females. To create both MeCP2-KO mice that expressed Td.Tomato in 
their PV cells and WT littermates that also expressed Td.Tomato in their PV cells.  
 
Solutions: Slices were conserved in standard carbogenated (95% O2 and 5% CO2) artificial cerebrospinal 
fluid (ACSF) containing (in mM): 130 NaCl, 3.5 KCl, 2.5 CaCl2, 1.5 MgSO4, 24 NaHCO3, 1.25 NaH2PO4, 
and 10 glucose. The recording pipettes was filled with a 5mM or 500μM solution of unconjugated 
AlexaFlour488 biocytin at 50μM concentration (Invitrogen, Life Technologies) and intracellular solution. 
The intracellular solution contained (in mM): 100 CsOH, 0.6 EGTA, 5 MgCl2, 8 NaCl, 2 Na-ATP, 0.3 Na-
GTP, 40 HEPES, 0.1 Spermine and 1 QX-314. 
Whole-Cell Filling and Recording:  Coronal brain (300 μm) sliced using a Leica VT1200 (Leica 
Microsystems) were collected from WT and MeCP2 KO mice. Slices were submerged in ACSF at room 
temperature for at least 1 hr. Experiments were performed in a recording chamber on the stage of an 
microscope equipped with differential interference contrast (DIC) optics for visualization. Cell response 
and was recorded from layer IV-V neurons of V1 with an Axon 200B amplifier (Molecular Devices Inc., 
Sunnyvale, CA, USA) using patch pipettes (3-5MΩ) made from thin-wall (1.5mm outer diameter, 0.86mm 
inner diameter) glass using a vertical electrode puller. Neurons were voltage-clamped at -60 mV. The 
recording duration time was 10-20min. Tissue slices containing biocytin-filled cells where fixed by 
immersion in 4% paraformaldehyde in 0.01mM phosphate buffered saline (PBS) overnight at 4°C.  
Resectioning: The fixed coronal slices were resectioned by transferring them to a 4% weight-volume 
low-melting point agar (Sigma-Aldrich) PBS solution. The agar-PBS solution was heated and mixed until 
uniform. The fixed slice were placed horizontally in the liquid agar-PBS solution and left to solidify for 5-
10 minutes. The resulting block is sectioned using a Leica VT1200 (Leica Microsystems) into 80μm slices. 
The sections were mounted on VWR Superfrost Microslides (VWR Lab, Batavia, IL) using a solution of 
0.003 mM phosphate buffer (PB).  
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Tyramide Signal Amplification Protocol: A tyramide signal amplification kit was bought from Invitrogen. 
The biocytin filled cells on the mounted sections were permeableized with 0.2% Triton-X. The sections 
were rinsed in PBS and incubated with a 1% blockin solution (Invitrogen) for one hour. The slices 
underwent 3 PBS washes of 5 minutes each. The slices were incubated labeled with conjugated 
streptavidin-HRP in a 1:100 solution with the 1% blocking agent for one hour. The sections were again 
washed with PBS. The sections were incubated in an amplification buffer containing 0.0015% H2O2 and 
AlexaFLour488-labeled tyramide solution for 10 min at room temperature. The sections were 
coverslipped with VECTASHIELD Hard-Set Mounting Medium with DAPI (Vector Laboratories) and left to 
dry overnight. 
Confocal Microscopy and Reconstruction: Sections were imaged under a LSM 5 Pascal Zeiss Confocal 
Microscope. Images for reconstruction were obtained using a 63x oil-immersion objective. 
Reconstruction was done using Neurolucida (MBF Bioscience) and the morphological analysis was done 
using Neuroexplorer (MBF Bioscience).  
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Chapter 5: Projects Strategy 
 
5.1 Stakeholders  
 Before the specifics of the design process are further discussed, it is important to properly 
identify the stakeholders in this project. The stakeholders were defined as: clients, designers and users. 
They are show in Figure 8 below:  
 
Figure 8: Project Stakeholder Diagram 
 
 The main stakeholder in this project is the MQP group. The group will not only design 
the bioreactor, but also use it in our electrophysiology experiments. Therefore, we are also in 
charge of determining its objectives and functions.  
 The clients were considered to be the evaluators of the final design. Therefore, this 
group includes the users, the MQP group and other researchers in need of a brain slice 
incubation chamber, who will be determining the efficiency of the design. The Project Advisors 
were included in the client group as they will be assessing how effectively the design process 
was carried out and how successfully the objectives and constraints were met.  
 
Designers: 
MQP Group 
Users: 
-MQP Group 
- Researchers 
Clients:  
- Project Advisors 
- MQP Group 
-  Researchers 
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5.2 Initial Client Statement  
 The clients of this design project are researchers using electrophysiology or a tissue 
incubation apparatus for their research, as well as the project supervisors.  The initial client 
statement was the result of conversations with other users of slice incubation chambers. The 
users agreed that the current device was not optimum and that slice viability is indeed 
hindered, affecting the result of their experiments. The initial, unrefined client statement can 
be described as follows: 
“Design a bioreactor to: 1) conserve brain slices and optimize their viability for use in 
electrophysiology experiments, 2) contain the appropriate incubation media and withstand 
physiological conditions and 3) is inexpensive and/or easy to make” 
 This client statement was further refined as the design process progressed. A refined 
client statement will be presented later on in the chapter 
5.3 Objectives  
 In order to develop a more refined client statement, a complete list of objectives was 
developed. The primary list was pruned into a definite list of objectives. The definite list was 
divided into primary and secondary objectives using an objectives tree, which can be seen in 
Figure 9. The primary and secondary objectives were compared using pairwise comparison 
charts (located in Appendix A: Pairwise Comparison Charts) in order to quantitatively weigh their 
importance as design considerations. The calculated weight of the primary and secondary 
objectives can be seen as bolded numbers in Figure 9. The weight of the secondary objectives 
was calculated based on the weight of the primary objective. The remainder of this section will 
focus on analyzing and detailing the objectives. 
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Figure 9: Objectives Tree for Tissue Incubator 
 
5.3.1 Maintain Slice Viability 
 The most important objective, as measured by the Pairwise Comparison Chart in Table 3 
in Appendix A: Pairwise Comparison Charts, is that the device be able to maintain the viability of 
the brain slices. It is the main function this device must be able to carry out. If this objective is 
not met and the bioreactor actually hinders the brain slice viability, the device will have failed in 
its purpose and cannot be used.  There are many specific functions and specifications which 
must be met in order for the incubator to maintain slice viability. 
 One of these functions is that the device must be able to hold oxygenated aCSF at a pH 
of 7.2-7.5. The aCSF is oxygenated during incubation by the diffusion of carbogen, a gas that 
Create a 
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contains 95% O2 and 5% CO2 [16]. Direct contact between the gas bubbles and the tissue is 
harmful to the tissue’s viability and must be avoided [39]. To protect the slices from the 
bubbling, they are placed on a mesh which disrupts the bubbles before they reach the samples.  
Another important function is to protect the slices from outside contamination. If the designed 
device allows uncontrolled exchange with the external environment it could allow the entry of 
contaminating agents, compromising the slice’s viability. These were not separated and 
evaluated as secondary objectives as they were all initially considered to be equally important.  
5.3.2 Stability  
 The purpose of this bioreactor is to incubate the acute brain slices until they reach 
steady-state conditions [16]. Therefore, this device must be able to maintain a desired 
condition for an extended period of time. In order to achieve a steady-state condition, the 
bioreactor must be stable both mechanically and thermally.  
 Mechanically, the incubator must be sturdy and not agitate or deform the slices. 
Thermally, the device should be able to keep the slices at a constant temperature and be able 
withstand temperature around physiological conditions (21-37°C)[40].  If the device fails in any 
of these cases, the slices will not reach a steady state and their viability will be hindered. 
Mechanical stability was considered to be more important than thermal stability because more 
slice deterioration occurs from lack of mechanical stability.  
5.3.3 User Friendly  
 As a general objective “user friendly” entails that the device must be simple enough for 
any researcher to use in a typical experimental setting. In the case of the slice incubator, ease 
of use entails a variety of secondary objectives including: maintenance and interface with an 
electrophyisiology recording rig.  
 The device must be maintainable as it is designed for multiple uses. If the incubator 
needs to be replaced for every experiment, then it has failed its purpose. Maintainability also 
entails ease of cleaning and reparability of the device. If the device is difficult to clean, it 
compromises the integrity of both the slice and incubator and would be considered a failure.  
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 Because the purpose of the device is to conserve slices to be used in electrophysiology, 
it was established that the new apparatus should be interfaceable with a recording “rig”. This 
would make the experimental preparations more straightforward and diminish the handling of 
the slices.  Maintenance was considered more important than interfaceability because if the 
final design is difficult to maintain, regardless of it being interfaceable or not, it will be 
considered a failure.  
5.3.4 Easy To Make  
 This objective is very straightforward: if the device is not easily manufacturable, it will 
be considered a failure. Manufacturability can be subdivided into two main secondary 
objectives: cost-effectiveness and material feasibility. 
 The final product should be cost effective in the sense that it should be as inexpensive 
as possible to make, considering its desired functions. Material feasibility refers to the 
availability of materials that are qualified to manufacture the device. If the desired functions 
like little cell interaction, little thermal and electrical conductivity, transparency, specific weight, 
etc. can only be achieved with a rare or unprocessable material, the desired functions will need 
to be revisited. Cost-effectiveness and material feasibility were considered to be equally 
important. 
5.3.5 High Throughput  
 For the sake of this project, throughput is defined the ability to handle a large amount of 
samples at the same time. Many times these experiments require handling slices from different 
brain samples. It is important that this device be able to provide an appropriate environment to 
support them. If this device is only able to support slices coming from one brain, then it will be 
considered a failure. Because this device will handle different samples, it is important that there 
be separate slice incubation chambers. 
5.4 Constraints 
 In order to reduce the design space and produce a design that meets the client’s needs, 
constraints were established. The major constraints are represented in Figure 10.  The most 
important constraints and their implications are further discussed in this chapter. The 
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constraints were used to evaluate the design alternatives. If a design did not meet an 
established constraint, it was rejected.  
 
Figure 10: Schematic of main constraints and their implications 
5.4.1 Size and Weight 
 The final incubator must be small enough to fit on a crowded lab bench. For successful 
slice incubation, the slices must be transferred directly from vibratome to the bioreactor. 
Vibratomes are bulky and occupy an important area of the lab bench. Therefore the final design 
must be small enough to be able to fit together with the vibratome on a lab bench. 
 The final incubator also must be portable. If the final design is attachable to the 
electrophysiology rig, it would be inconvenient to require more than one person to move the 
device to its required location. This constraint will also be important when choosing a material 
for the chamber. Size and weight specifications will be further discussed in Chapter 6.  
Constraints 
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5.4.2 Safe 
 The final design must be safe for both the user and the slices. In regards to user safety, it 
is important that the incubator does not put the researcher at risk by exposure to biohazardous 
substances that could be used during specific incubation protocols. It is also important that 
outer surface of the final design not have sharp edges to avoid glove and skin ruptures that 
compromise the safety of the researcher. In regards to slice safety, the final design must not 
compromise the viability of the slice throughout incubation. It must also protect the slice from 
possible external contaminants. 
5.4.3 Time 
 The deadline for this project is currently at the end of C-term, meaning March 1st, 2013.  
5.4.4 Budget 
 The final prototype should require no more than $200 to design, test and complete.  
5.4.5 Material Constraints 
 It is extremely important to choose the appropriate material out of which to make the 
incubation chamber. In order to consider a material appropriate it must have the following 
characteristics: non-conductible, sterilizeable, transparent and biocompatible. 
 If the material were to conduct heat and electricity from external sources, it would not 
be able to isolate the slices or keep them at a steady state condition. If the material is not 
sterilizeable, there are higher chances for contamination of the slices. Transparency of the 
incubation chamber would allow the researcher to easily locate and monitor the slices. 
Biocompatibility of the material is essential; the material must not create a cell-toxic 
environment.  
5.5 Revised Client Statement  
 After a detailed analysis of the objectives and constraints and a review of the current 
technology, the initial project statement was revised and expanded. Aspects that were added 
to the client statement are underlined in the revised client statement 
 The revised client statement is as follows: 
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“Design a bioreactor which:  
1) Conserves brain slices and optimize their viability for use in in vitro electrophysiology 
experiments by providing a sterile and biocompatible environment, protecting the slices from 
direct contact with gas bubbles, external contaminants and mechanical instability. 
2) Can contain artificial cerebrospinal fluid (aCSF) oxygenated through carbogen (95% O2 and 
5% CO2) bubbling. 
3) Withstand physiological conditions (pH of 7.2-7.5 and a temperature of 21-37°C. 
4)  Fits on a crowded lab bench and can be handled/moved/carried by one person. 
3) Meets the specified time (done by March 1sy, 2013) and budget ($200.00 for design and 
manufacturing) constraints. 
4) Is made of a non-conductible, sterilizeable, transparent and biocompatible material.   
5) Is safe for human use in a research setting.”  
5.6 Project Approach 
 Once the objectives and constraints were identified, the project approach was 
developed. But before specific aims could be identified, it is important to understand the slice 
incubation process. The process was divided into three separate stages, which can be seen in 
Error! Reference source not found.. The device is first filled with aCSF that is oxygenated through 
 bubbling mechanism in the apparatus (1 in Figure 11). A freshly sectioned slice inserted into 
the device (2 in Figure 11); and after the desired incubation period it is extracted from the 
bioreactor (3 in Figure 11). These three stages will be discussed in more detail in the project 
approach chapter.  
 
Figure 11: Process of Slice Incubation in Oxygenated artificial CerebroSpinal Fluid (aCSF) 
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 Because of the variety of required functions throughout the process and the anticipated 
challenges, the project approach was divided into three Steps. In order for a design to be a 
considered a viable solution it will have to successfully pass each step successfully.  
 Step 1:  Demonstrate that the designed device does not interact with the 
incubation media and minimizes tissue interaction with external environment. 
 In order to pass this “Step”, the presented material of which the incubator is made of 
must not interact with the internal incubating solution. In regards to the internal solution, the 
composition of aCSF varies depending on the parameters being studied. But chemically aCSF 
can be classified as a standard HCO3 buffer with the main components being Calcium, 
Magnesium, Chloride and Sodium. Some formulations use glucose, dextrose or sucrose [40-42]. 
Some work is also conducted with non-HCO3 buffers, including HEPES and phosphates [40, 43, 
44]. All of these materials need to be at physiological pH (7.1-7.5). The most successful 
incubations occur when concentrations and pH remain unaltered throughout the three steps 
mentioned above. In order to demonstrate that the designed device does not affect any of 
these characteristics, the appropriate material must be chosen to make the incubation 
chambers. This material must be shown to be resistant to the designated pH and not interact 
with any of the components of aCSF, Hepes and other typical slice incubating solutions.  
 The motivation behind the isolation of the contents of the incubation chamber is that 
external conditions are usually beyond a researcher’s control and can be very variable. Factors 
like atmospheric humidity and variable temperature gradients have been shown to hamper 
brain slice incubation[40]. Therefore the chosen material must have poor conductive properties 
and the design must physically isolate the slices and incubating solution during stage 2 of the 
slice incubation process outlined in Figure 11. The design must also allow for minimal 
interaction with the external environment at stages 1 and 3.  
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 Step 2:  Demonstrate that the designed device provides a stable and sterile 
environment for brain slices to achieve a steady-state.  
 It has been shown that uncontrolled mechanical variations can distress live cells, causing 
unwanted cell death. Providing a stable environment for the slices during stage 2 of the slice 
incubation process is essential to maximize the number of live cells that can be used for 
recording. This objective needs to be met by designing a device that maintains the slices in 
equilibrium and isolates the internal environment from external vibrations. 
 In order to provide a sterile environment, the design must be easy to clean and made of 
material demonstrated to be sterilizeable. The method of sterilization can be varied: through 
ethanol, autoclaving, etc.  
 Step 3:  Demonstrate the ability of the design to maintain slice viability by 
comparing incubated slices with acute non-incubated slices and values found in the 
literature.  
` The final step for the validation of a design alternative will be to test the viability slice of 
the incubated slices. The standard method of slice viability testing is to compare a set of 
parameters in a non-incubated and an incubated slice. Values can also be compared to 
established in vivo values. Slice viability has been characterized through metabolic activity, 
morphological and electrophysiological characterization [40, 45]. Due to the time and monetary 
constraints of this project, we can only compare morphological and electrophysiological 
characteristics. Cell morphology and overall slice appearance of incubated slices can be 
compared to non-incubated slices through microscopy and electrophyisiological characteristics 
can be compared to values found in the literature using whole-cell patch-clamping. The reason 
electrophysiological characteristics cannot be compared to non-incubated slices is because they 
are not in a steady-state, causing alterations in cell firing, membrane potential and resistivity 
compared to in vivo conditions.  
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Chapter 6: Alternative Designs 
6.1 Needs Analysis  
 Neurological disorders affect at least 1 billion of the world’s population [46]. In many 
neurological disorders, including Rett Syndrome, the morphology and connectivity of the cells 
have been to be severely altered.  Electrophysiology is the gold standard technique for studying 
neuron morphology and connectivity. As it was mentioned before, the success of these 
recordings depend on the viability of the brain sample that is used. Mammalian models (mice 
and rats usually) are preferred for the study many of these disorders and possible treatments 
because of the homology with the human central nervous system. The development and 
maintenance of these animal models can be a very expensive process. Therefore, being able to 
appropriately conserve these slices to ensure their viability for electrophysiological experiments 
is crucial. By designing a better slice incubator, the success rate of these experiments can be 
improved.  
6.2 Functions, Means and Specifications 
 In order to aid in the brainstorming process, a functions-means chart was created. The 
chart can be seen in Table 1. These means not only present a solution to fulfill the necessary 
functions but are also in line with the objectives and constraints presented in the Chapter 5. 
The functions-means chart establishes more than one possible mean to accomplish each 
function. The functions-means chart was used as a tool to develop four design alternatives that 
will be later discussed in this chapter. This section discusses the functions and the means 
considered to fulfill each function. 
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Table 1: Functions-Means Chart for a Slice Incubator 
 
 6.2.1. Carbogen Exchange:  
 In order to provide the appropriate conditions for cell maintenance, the incubation 
media (artificial cerebrospinal fluid or aCSF) must be oxygenized with carbogen. Carbogen is a 
mixture of oxygen and carbon dioxide (usually 95% O2 and 5% CO2) [16]. Carbogen is usually 
provided through internal piping systems. Three means have been identified to provide the 
appropriate carbogen exchange with the aCSF, through an attached exchanger, a separate 
exchanger within the incubator or through a separate gas exchange container. 
 6.2.1.1 Attached Exchanger: 
 Using an attached exchanger, the piping from the carbogen source can be attached 
directly into the incubator. The attached exchanger would provide a mesh to create small 
carbogen bubbles that would diffuse through the incubator.  
 6.2.1.2 Separate Exchanger:   
 With the separate exchanger, the piping coming from the carbogen source would need 
to end in a mesh material that would create bubbles when immersed in the aCSF.  
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 6.2.1.3 Separate Container for Gas Exchange 
 Using a separate container for gas exchange would mean that there is no gas diffusion 
occurring directly in the slice incubator and that the aCSF in the slice incubator would be pre-
oxygenated. The diffusion in the separate container could occur with either an attached or 
separate exchanger.  
6.2.2 Contain Brain Slices 
 The whole purpose of designing this device is to be able to incubate brain slices. 
Therefore it is crucial that the incubator be able to contain them appropriately. To satisfy this 
function, three means have been identified. The device could have included slice holders, 
separate slice holders or a slice holding area that is not an individual container. 
 6.2.2.1 Included Slice Holders 
 The included slice holders would be included in the incubator and would not be able to 
be removed. This provides greater mechanical stability but could also hinder the ease of use 
and ability to clean the device. If carbogen exchange were to occur in the same container 
where the slices are incubated, the slice holder bottom would need to be made of a mesh 
composed of a biocompatible material. The mesh would allow for the carbogen bubbles to not 
burst on the tissue surface, causing traumatic cell death. These slice holders would be large 
enough to snuggly fit the length of one brain slice. 
 6.2.2.2 Separate Slice Holders   
  The design considerations of separate slice holders would be the same as the included 
ones. The only difference would be that these slices would not be attached to the media 
container of the slice incubator. This would make the device easier to clean but mechanically 
less stable. 
 6.2.2.3 Slice Holding Area 
 A slice holding area would be included in the incubating device. These areas would be 
larger than the length of one brain slice and would have divisions to be able to distinguish 
between different populations of brain slices. This area must also have a mesh bottom of a 
biocompatible material if the carbogen exchange occurs in the same container as the slice 
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incubator. This would allow for a higher throughput but would hinder the ease of use and limits 
its ability to be cleaned and sterilized. 
6.2.3 Contain Incubation Media 
 In order to appropriately incubate the slices, the material must be able to contain the 
appropriate incubation media. The incubation media for brain slice preservation is artificial 
cerebrospinal fluid (aCSF). There are two ways to achieve this: either by controlling for material 
properties or by using the proper material coating. In case of material properties, the material 
used must be hydrophilic in order to properly contain the media and not react with the 
components of the aCSF. If a desired material would like to be used but does not have one of 
those both characteristics a material coating could be applied on the surface of the material. 
The final design should be able to hold 500 mls of aCSF. 
6.2.4 Provide Mechanical Stability 
 In order for the slices to reach steady state and minimize cell death, mechanical stability 
must be maintained throughout the incubation period. A variety of means have been identified 
that would satisfy this function. These include a separate mechanical isolation chamber, 
controlling the mechanical and design properties and an adhesive bottom. 
 6.2.4.1Mechanical Isolation Chamber: 
 This chamber could be made of isolation material and would allow the slices to not be 
affected by the movements of the external environment. The incubator would be placed inside 
of this device and taken out once the incubation is done. 
 6.2.4.2 Material Properties: 
 By controlling the density and weight of the material one could make a device that 
would be stable mechanically. The device is specified to be at least 1kg of weight without the 
aCSF.  
 6.2.4.3 Design Considerations: 
 By taking into account design considerations like a flat bottom, the design would be 
stable on top of a lab bench.  
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 6.2.4.4 Adhesive Bottom 
 An adhesive bottom would allow for added stability during the incubation, it could also 
support the device through any sudden movements of the external environment.  
6.2.5 Provide Thermal Stability 
 The whole purpose of designing this device is to be able to incubate brain slices at a 
steady state. Therefore it is crucial that there are no sudden or extreme temperature gradients. 
To satisfy this function, two means have been identified. Much like the mechanical stability 
function, this device could be contained in a thermal isolation chamber made out of thermally 
insulating material. Another way to control for this would be by making the incubator out of a 
thermally unconductive material.  
6.2.6 Protect the Tissue from the Environment 
 In order to avoid contamination from the external environment, the device must be able 
to  protect the slices from outside contaminants. The presence from external contaminants 
could promote cell death. Three means have been established to satisfy this function. A 
separate isolation chamber could be used during incubation. Another mean would be using an 
attachable or separate lid. An attachable lid would be included in the design while a separate lid 
could be something like aluminum foil. 
6.2.7 Easy Slice Access  
 To be able to place the slices in the incubator and move the slices from the slice 
incubator to the electrophysiology rig stage, the slices must be easily accessible. There are a 
variety of means this could be satisfied. By using an attachable or separate lid or no lid it will 
allow for easy slice access when needed. Another option is not using a lid but an access window 
on the material. Another important mean is by using a transparent material that would allow 
for proper guidance when selecting the slices. 
6.3 Design Alternatives 
 Based on the functions and specifications discussed above, four design alternatives were 
established. These designs are described in detail in this chapter.  
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6.3.1 The “Lobster Pot” Design:  
 The “Lobster Pot” Design consists of a cylindrical container with an attachable lid to 
protect the slices from the environment. The device consists of a flat bottom with adhesive 
material for added mechanical stability. The device would be made of a transparent material. 
There would attached slice holders and gas exchanger. Sketches of this design can be seen in 
Figure 12. The functions-means chart for this design can be seen in Table 7. 
 
  
 
 
 
 
 
 
 
 
 
  
Figure 12: Lobster Pot Design 
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6.3.2 Attachable Slice Holders  
 These attachable slice holders could be placed on any container. Separate slice holders 
could be attached in a slice holder holder in order to increase their stability and high 
throughput of the device. Because this device does not have a media container in itself, it 
would need a separate gas exchanger. The individual slice holder would be made of a metallic 
mesh to allow for proper gas diffusion on to the slices. The slices would be protected from the 
external elements both by the container and a separate lid. Sketches of this design can be seen 
inFigure 12. The functions-means chart for this design can be seen in Table 8. 
 
Figure 13: Attachable Slice Holder Design 
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6.3.3 Well Slice Holder Design 
 This design is the most elaborate of all the design alternatives. This device includes a 
separate gas exchange chamber. Once the aCSF is oxygenated, it flows to the well slice holder 
through a peristaltic pump or gravity. The slices are incubated in a well slice holder which is 
constantly infused with the oxygenated aCSF. The aCSF is taken out of the well chamber 
through another peristaltic pump that deposists the fluid back in the gas exchange container. 
Sketches of this design can be seen inFigure 12. The functions-means chart for this design can 
be seen in Table 8.  
 
 
Figure 14: Well Slice Holder 
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6.3.4 “Three Layer” Incubator Design 
 This design consists of a three layers: a lid, a slice holding area and the media container. 
The lid would have a movable window to allow for easy slice access. The slice holding area 
would allow for a higher throughput of slices. This area would interlock with media container to 
allow for greater mechanical stability of the slices. The third layer would have attached gas 
exchanger. This was decided based on the tightness of the three layer system that would not 
allow for tubing to come out of the device. A sketch of the device can be seen in Figure 15  and 
the functions means chart of the device can be seen in Table 10.  
 
 
Figure 15: "Three Layer" Incubator 
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6.4 Conceptual Tentative Final Design: 
6.4.1 Design Selection: 
 The four alternative designs were evaluated through a design evaluation matrix. The 
selections matrices for objectives, constraints and functions can be seen in Appendix C: Design 
Evaluation Matrices. Designs were evaluated on a scale from 0 – 2 depending on how well they 
met the designated objective, constraint or function. Designs were not disqualified based on 
not fully meeting a constraint; it was considered that if the design were good enough, those 
constraints could be worked out. A summary of the design evaluation matrices can be seen in 
Table 2. The point from the objectives, constraints and functions decision matrices were added 
up in order to choose a final design. The final conceptual design was the attachable slice holder 
design. 
Table 2: Final Decision Matrix 
 
6.4.2 Attachable Slice Holder Design Details: 
 The attachable slice holder has many advantages. First of all it is very easy and cheap to 
manufacture. Second there is no need to design a separate container: a typical beaker or Pyrex 
® container provides the material and mechanical properties necessary to contain the media at 
a stable temperature and not interact with its content. The following section describes in more 
detail the two main components of the design, the slice holder and the slice holder-holder. 
6.4.2.1: Slice Holder: 
 As it was explained in the previous chapter, the slice holder would be made of a metallic 
mesh. It was decided so because of its greater stability and its availability on the market. 
Further analysis must be conducted on the types of meshes available on the market and their 
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biocompatibility.The mesh size would be between 0.10 and 0.70mm. The top of the slice holder 
would be open to allow for sample placement. The internal circumference of the slice holder 
would be from 3-5cm in diameter. The slice holder would also have an outreaching 
circumference on the top to allow for the individual slice holder to be mounted on the slice 
holder holder. This greater circumference would be from 5-7cm. It would not need to be made 
of mesh material. The most appropriate material could be a simple thermoset polymer, but 
further investigation must be conducted. For reference, a sketch of the individual slice holder 
can be seen in Figure 16. 
 
Figure 16: Individual Slice Holder 
 
6.4.2.2: Slice Holder Holder: 
 The purpose of this device is to be able to increase the stability and sample number that 
this design can handle.  This design must be made of a strong and brittle yet lightweight, 
therefore we are considering thermoset polymers. This design would attach on to the media 
container. The current design would allow for three individual slice holders to be contained..For 
reference, a sketch of a slice holder-holder can be seen in Figure 16. 
 
Figure 17: Slice Holder-Holder 
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6.3 Feasibility Study and Experimental Methodology 
 
6.3.1 Feasibility Study: 
 In order to test the feasibility of manufacture of the design, first a extensive study must 
be done on what materials and similar devices are currently on the market. Because of the 
simplistic nature of this design, we do not anticipate a problem with the manufacturability of 
any of the design parts. If need be, the design should be adapted. In order to test the 
conceptual design, a prototype can be fashioned with the most readily available material.  
 Another important part of the feasibility study includes the material selection for the 
individual parts of the device. The details for the needed qualities of these materials can be 
seen in Chapter 5 and in earlier sections of this chapter. 
6.3.2 Experimental Methodology: 
 In order to test the device, we will Step 3 described in the Project Approach section of 
Chapter 4.  The final step for the validation of a design alternative will be to test the viability 
slice of the incubated slices. The standard method of slice viability testing is to compare a set of 
parameters in a non-incubated and an incubated slice. Values can also be compared to 
established in vivo values. Slice viability has been characterized through metabolic activity, 
morphological and electrophysiological characterization [40, 47]. Due to the time and monetary 
constraints of this project, we cannot test the efficacy of our chosen design. Studying the 
changes in cell morphology would be the easiest way of comparing the two designs. Cell 
morphology and overall slice appearance of incubated slices can be compared to directly 
harvested non-incubated and slices incubated in distilled water slices through microscopy.  
6.4 Preliminary Data 
 As it was explained in the previous chapter, we would need to compare our incubated 
slices to acute non-incubated slices. In order to establish cell viability, we can look at cell 
morphology. When neurons undergo apoptosis, their volume increases and they acquire a 
more rounded shape [16]. The incubated slices should have the least amount of cell volume 
increase compared to the directly harvested non-incubated slices, which are the positive 
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control. For the negative control, the slices can be incubated in distilled water. Water lacks the 
necessary minerals and oxygen required for cell maintenance and therefore will be non-viable 
slices. Therefore, the cell bodies of the incubated slices must also have less volume than the 
water incubated slices. 
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Chapter7: Results: 
 
7.1 Electrophysiological Filling: 
 Pyramidal cells and interneuron in Primary Visual Cortex (V1) were selectively filled through 
whole cell patch clamping using biocytin and AlexaFlour 488. Two different mixtures of these 
component were used. The pyramidal cells were filled using a conjugated form the AlexaFlour 488 and 
the biocytin.  The interneurons were filled with a solution that contained an unconjugated form of the 
AlexaFlour 488 and the biocytin. By filling the cell with AlexaFlour488, we were able to image the cells as 
we were recording them to ensure that soma and dendritic arbor were being filled with the biocytin. In 
Figure 18 we can observe representative images of how the filled cells appear after the recordings are 
finished.  
 
Figure 18: View of the filled cell in the electrophysiology rig. A. Differential interference contrast (DIC) view of V1 in a brain 
section at a 10X magnification. B. 10X view of a pyramidal cell filled with the biocytin-AlexaFlour 488 conjugated solution 
spanning from layer II/III to the plial surface taken using a Green Fluorescent Protein (GFP) filter. C.40X magnification of the 
cell soma taken using a GFP filter 
  
 For the interneuron experiments, we only used cells that selectively expressed Td.Tomato in 
their Parvalbumin cells. After locating V1, these cells were identified under a Red Flourescent Protein 
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(RFP) filter. As the mice were still relatively young (P20-30), Td. Tomato was not ubiquitously expressed 
in the cell but rather in puncta in the cell soma. This can be more clearly seen in Figure 19. 
 
Figure 19: Selective patching of a PV expressing cell. A. PV expression seen at 40X through a Red Fluorescent Protein (RFP) 
filter. B. 40X magnification of a cell soma that expresses PV that is being filled with an unconjugated solution of 
AlexaFlour488 and biocytin. 
 
7.2 Confocal Imaging: 
 Once the cells were filled and recorded, they were fixed overnight and resectioned using the 
protocol described in the Materials and Methods section. The pyramidal cells which were filled with the 
conjugated AlexaFlour488-biocytin mixture were directly placed onto slides and imaged under a 
confocal microscope. We found that this approach hindered the image quality, as the fluorescence of 
the cell was significantly reduced. The brain sections containing the interneurons filled with the 
unconjugated AlexaFlour488 and biocytin solution were subjected to a Tyramide Signal Amplification 
(TSA) protocol. Tyramide Signal Amplification (TSA™) is an enzyme-mediated detection method that 
utilizes the catalytic activity of horseradish peroxidase (HRP) to activate an AlexaFlour488 molecule 
which is bound to streptavidin through a redox reaction. The streptavidin covalently bonds to the 
biocytin inside the filled cells. This reaction allows for an increased fluorescent signal of the filled cell.   
All sections were mounted on slides, coverslipped and stained with DAPI. 
 Using a fluorescent confocal microscope, cells were identified and images were taken on 
different z-planes. The collections of images obtained at different z-planes are referred to as z-stacks. 
Cells were identified using 10x and 20x imaging and z-stacks for reconstruction were taken at 63x. Cells 
were identified using both GFP and DAPI fluorescence filters and images for reconstruction were only 
taken using the GFP fluorescence filter. An example of images in a z-stack can be seen in Figure 20. 
These images were used to reconstruct the cell using Neurolucida. 
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Figure 20: Three images taken at 63X of the same x and y coordinates with varying z-plane. This cell was subjected to the TSA 
protocol. 
 In some cells it was the case that their dendritic arbor and the cell some were on different brain 
sections. An example of this case can be seen in Figure 21 . In these cases z-stacks were taken of both 
sections and reconstructed together using Neurolucida. 
 
Figure 21: Dendritic arbor and cell soma taken at 20X from different resectioned brain sections. 
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7.3 Pyramidal Cells:  
 A total of six pyramidal neurons, three MeCP2 KOs and three WTs, were filled and reconstructed 
(Figure 22A and 22B respectively show representative reconstructions of these populations). Pyramidal 
cells were identified by the presence of an apical dendrite and spines. All four cells were also identified 
as Regular-Spiking (RS) cells [15]. Three types of analysis were done: branch analysis, Sholl analysis and 
Convex-Hull Analysis on the basal dendrites of the cells. 
1. Branch Analysis: Number of branches per branch order, overall process length and average 
number of terminal ends were measured for each cell (Figure 22C,22D,22E respectively) 
There was no apparent difference between the MeCP2 KO and WT pyramidal cells. 
2. Scholl Analysis: Scholl analysis is used to analyze the extent of dendritic branching by 
counting the number of intersects with concentric circles with increasing radius. While the 
MeCP2 neurons showed increased number of intersects at a radius larger than 110μm 
(Figure 22F), the number of samples (n=3) is insufficient to conduct any statistical analysis. 
3. Convex-Hull Analysis: The Convex-Hull analysis is used to measure the area covered by the 
basal dendritic arbor. The basal dendritic arbor of the MeCP2 KOs seem to cover less area 
than the WT pyramidal cells (Figure 22G). These results will have to be further validated by 
increasing the sample size. 
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A B 
C D E 
F 
G 
Figure 22: Analysis of pyramidal cells. Reconstruction of MeCP2 KO (n=3) (A) and WT (n=3)  (B) cells. Branching analysis including branch 
order (C), overall process length (D), average number of temrinal ends (E). Number of intersections per Scholl radius (F) with a a 
representative image. Convex-Hull Analysis, emasuring average area covered per cell (G), with an illustration of how the area was 
measured.  
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7.4 Interneurons:  
 A total of three interneurons were filled, one WT  neuron and two MeCP2 KO (Figure 22A and 
23C respectively). It was realized that these two cells present very different morphology: the cell 
reconstructed in Figure 23A is clearly a double-bouquet or bitufted cell whereas the cell reconstructed in 
Figure 23C is clearly a basket cell. It is impossible to compare the morphology between these two cells. 
Therefore for our analysis it was necessary to use morphological data collected from another member in 
the lab[48] which can be seen in Figure 23B. Runyan et al. studied the morphology of WT PV- 
interneurons in V1 using 2-photon microscopy. The same three types of analysis were conducted: 
branch analysis, Sholl analysis and Convex-Hull Analysis on the dendrites of the cells. While the 
information of the bitufted cell reconstructed in Figure 23A were included for reference in the figures, 
they will not form part of our analysis. In Figure 23, the collected from the data from bitufted cell is 
labeled in black, the data of the WT basket cells from Runyan et al. can be seen in green and the MeCP2 
KO basket cells can be seen in red.  
1. Branch Analysis: Number of branches per branch order, overall process length and average 
number of terminal ends were measured for each cell (Figure 23D ,23E, 23F respectively) 
There was an important difference observed between the WT basket cells reconstructed by 
Runyan et al. and the MeCP2 KO cells. The MeCP2 KO basket cells showed diminished overall 
process length and number of terminal ends, as can be seen in Figure 23E and 23F. There was 
not a significant variation within the populations. One can start to infer that these cells seem 
to be much smaller and possibly cover less area. 
2. Scholl Analysis: As it can be expected because of its elongated morphology, the WT bitufted 
cell intersects at circles with a much higher radii than the basquet cells.  The WT basket cells 
of Runyan et al. seem to have both higher number of crosses per radii and longer span than 
the MeCP2 KO basket cell as it can be seen in Figure 23G. These results align with what was 
observed in the branching analysis and further suggests that there is a morphological 
difference between these two populations. 
3. Convex-Hull Analysis: There was no data for the WT basket cells of Runyan et al. available for 
the Convex-Hull Analysis. Regardless, the analysis was done with the WT bitufted cell and the 
MeCP2 KO basket cells. As can be seen in Figure 23H, the dendritic tree of the WT bitufted 
cell covers more area than the MeCP2 KO basket cell. This could be explained by the innate 
difference of the morphological characteristics of these cell types or an effect of the 
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genotype on the average area covered per cell. In order to confirm either of these 
hypothesis, we must obtain the data both from WT basket cells and MeCP2 KO bitufted cells.  
 
 
Figure 23: Analysis of interneurons. Reconstruction of WT bitufted cell (n=1) (A) , WT PV-expressing basket cells from Runyan 
et al. (n=13)  (B)  and MeCP2 KO PV-expressing basket cells (C). Branching analysis including branch order (D), overall process 
length (E), average number of temrinal ends (F). Number of intersections per Scholl radius (G). Convex-Hull Analysis, 
emasuring average area covered per cell (H). 
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Chapter 8: Conclusions and Future Work 
 
 The objective of this study was to do a morphological characterization of cortical neurons in a 
mouse model for Rett Syndrome. We have studied both pyramidal and interneuron morphology in 
Primary Visual Cortex (V1).  It is important to note that this work is currently ongoing and these results 
are preliminary.  
 These initial results hint at possible differences between WT and MeCP2 pyramidal cells in the 
area covered by the basal dendritic arborization although its overall reach, measured by Sholl analysis 
and the branching analysis is somewhat similar. In the case of the MeCP2 KO interneurons exhibit 
decreased area coverage and overall reach per cell as it can be seen in the branching analysis. Sholl 
analysis demonstrates larger process reach for WT basket cells. Convex Hull analysis demonstrates 
decrease in the average area covered per cell in the case of the pyramidal cells and possibly the basket 
cells as well. Both of these results have to be further validated by increasing the sample number of cells 
reconstructed. 
 The area coverage and reach decrease for both cell types could lead to a diminished integrative 
capacity in the MeCP2 knock outs. This is because as the processes are smaller, there is less probability 
of a synapse forming onto them. This in turn could lead to less synapses forming on the dendritic arbor, 
causing the cell to sample from a diminished input population and therefore producing an erroneous 
and non-WT like output. This hypothesis must be further validated with synaptic connectivity analysis 
using techniques like Immunohistochemistry to locate and count presynaptic and postsynaptic terminals 
on the dendrites.   
 Once these observed changes are confirmed through further experimentation, further analysis 
on the mechanisms of action of MeCP2 will be done. As it was previously stated, MeCP2 could be 
regulating the actin-modification signaling pathways through the activity of CDK5. CDK5 has been shown 
to promote neuronal morphogenesis and cortical development in vivo[31].  
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 Appendix  
Appendix A: Pairwise Comparison Charts  
 
Table 3 Pairwise Comparison Charts of Primary Objectives 
 
Maintain 
Slice Viability 
Stability 
User 
Friendly 
Easy 
to 
Make 
High 
Throughput 
Total Weight 
Maintain Slice 
Viability  
0.5 1 1 1 4 0.4 
Stability 0.5 
 
1 1 1 3 0.3 
User Friendly 0 0 
 
0.5 0.5 1 0.10 
Easy to Make  0 0 0.5  0 0.5 0.05 
High 
Throughput  
0 0 0.5 1 
 
1.5 
0.15 
 
Table 4 Pairwise Comparison Charts of “Stability” Secondary Objectives 
Stability Mechanically Thermally Total 
Weight (out of  
Weight of Stability) 
Mechanically 
 
1 1 0.20 
Thermally 0 
 
0 0.33 
 
Table 5 Pairwise Comparison Charts of “User Friendly” Secondary Objectives 
User Friendly Maintenance 
Interface 
with Rig 
Total 
Weight (out of  Weight 
of User Friendly) 
Maintenance 
 
1 1 0.067 
Interface with Rig 0 
 
0 0.033 
 
Table 6 Pairwise Comparison Charts of “Easy to Make” Secondary Objectives 
Easy to Make 
Cost-
Effective 
Material 
Feasibility 
Total 
Weight (out of  Weight of Easy 
to Make) 
Cost-Effective 
 
0.5 0.5 0.025 
Material Feasibility 0.5 
 
0.5 0.025 
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Appendix B: Functions-Means Charts for the Alternative Designs  
 
Table 7: Functions Means- Chart for Lobster Pot Design 
 
 
  
Table 8: Functions-Means Chart for Attachable Slice Holder Design 
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Table 9: Functions-Mean Chart for Well Slice Holder Design 
 
Table 10: Functions-Mean Chart for "Three Layer" Incubator Design 
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Appendix C: Design Evaluation Matrices 
 
Table 11: Objective Evaluation Matrix 
 
 
Table 12: Constraint Evaluation Matrix 
 
  
61 
 
Table 13: Function Design Evaluation Matrix 
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